Case Study | Tomorrow Biostasis

Client

Industry

BioTech

Website

Berlin-based Tomorrow Biostasis specializes in the innovative field of human cryopreservation. They required an enhanced online presence to effectively explain their services and foster trust with prospective clients. We delivered a custom Webflow solution engineered to clearly convey their offerings, build credibility, and significantly increase conversion rates.

The Challenge

‍

The primary challenge was structuring the website’s content and user experience to ensure visitors fully understood Tomorrow Bio’s complex services. Additionally, it was crucial to design the site in a way that fostered trust, given the sensitive nature of cryopreservation.

The Solution

‍
‍

Comprehensive Website Revamp: We undertook a complete redesign of Tomorrow Bio’s website, focusing on intuitive navigation and clear presentation of information. This overhaul aimed to make the user journey seamless and informative.
‍
Dedicated Landing Pages: To provide in-depth explanations of each service, we developed individual landing pages. These pages were tailored to address specific aspects of cryopreservation, ensuring that potential clients could easily access detailed information.
‍
Trust-Building Elements: Incorporating testimonials, detailed procedural explanations, and transparent pricing helped in building credibility and trust with the audience.

‍

Results

‍

The strategic redesign and content structuring led to a significant improvement in user engagement and conversions:
‍

Improved Bounce Rate: There was a 20% reduction in the bounce rate, reflecting that visitors were more inclined to explore multiple pages.
‍
Conversion Rate Increase: The revamped website achieved a 35% increase in conversion rates, indicating that more visitors were taking desired actions.
‍‍
Enhanced User Engagement: The average time spent on the site increased by 25%, suggesting that users found the content more engaging and informative.

Additional case studies

Medlanes: From Clicks to Clinic (and a 50% CAC Reduction)